A British pharmaceutical company has received an award for its work in prescription-based cannabis medicine. London-based GW Pharmaceuticals today announced …
A British cannabis-focused pharmaceutical company has received FDA approval for a medication to treat Tuberous Sclerosis Complex (TSC) seizures. Earlier …
Cannabis biopharmaceutical company GW Pharmaceuticals today announced that it has received a notification from the United States Drug Enforcement Administration …
As Thailand’s National Legislative Assembly approved legislation in late December to legalize medicinal cannabis use in the country, some established …